Seroatlas · Human Serome Atlas

MAPKAPK3

MAP kinase-activated protein kinase 3

Also known as: 3pK, MAPK3_HUMAN, MAPKAP3, MK-3, MK3

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q16644
Gene
MAPKAPK3
Ensembl
ENSG00000114738
Chromosome
3
Canonical length
382 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
Subcellular location
Nucleoplasm

OverviewNCBI Gene

This gene encodes a member of the Ser/Thr protein kinase family. This kinase functions as a mitogen-activated protein kinase (MAP kinase)- activated protein kinase. MAP kinases are also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This kinase was shown to be activated by growth inducers and stress stimulation of cells. In vitro studies demonstrated that ERK, p38 MAP kinase and Jun N-terminal kinase were all able to phosphorylate and activate this kinase, which suggested the role of this kinase as an integrative element of signaling in both mitogen and stress responses. This kinase was reported to interact with, phosphorylate and repress the activity of E47, which is a basic helix-loop-helix transcription factor known to be involved in the regulation of tissue-specific gene expression and cell differentiation. Alternate splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Sep 2011]

Canonical amino-acid sequenceUniProt

382 residues, UniProt reviewed canonical sequence.

>Q16644|MAPKAPK3
     1  MDGETAEEQG GPVPPPVAPG GPGLGGAPGG RREPKKYAVT DDYQLSKQVL GLGVNGKVLE
    61  CFHRRTGQKC ALKLLYDSPK ARQEVDHHWQ ASGGPHIVCI LDVYENMHHG KRCLLIIMEC
   121  MEGGELFSRI QERGDQAFTE REAAEIMRDI GTAIQFLHSH NIAHRDVKPE NLLYTSKEKD
   181  AVLKLTDFGF AKETTQNALQ TPCYTPYYVA PEVLGPEKYD KSCDMWSLGV IMYILLCGFP
   241  PFYSNTGQAI SPGMKRRIRL GQYGFPNPEW SEVSEDAKQL IRLLLKTDPT ERLTITQFMN
   301  HPWINQSMVV PQTPLHTARV LQEDKDHWDE VKEEMTSALA TMRVDYDQVK IKDLKTSNNR
   361  LLNKRRKKQA GSSSASQGCN NQ

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against MAPKAPK3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.33
Highest tissue expression
265 nTPM

Expression across tissuesHPA

Tissue

  • tongue: 265 nTPM
  • heart muscle: 242 nTPM
  • skeletal muscle: 213 nTPM
  • bone marrow: 101 nTPM
  • skin: 52 nTPM
  • esophagus: 49 nTPM

Single-cell type

  • esophageal apical cells: 175 nCPM
  • late spermatids: 170 nCPM
  • hofbauer cells: 128 nCPM
  • esophageal suprabasal cells: 123 nCPM
  • esophageal basal cells: 87 nCPM
  • megakaryocytes: 87 nCPM

Immune cell

  • non-classical monocyte: 343 nTPM
  • intermediate monocyte: 272 nTPM
  • classical monocyte: 170 nTPM
  • myeloid DC: 143 nTPM
  • total PBMC: 133 nTPM
  • eosinophil: 127 nTPM

Brain region

  • medulla oblongata: 33 nTPM
  • spinal cord: 29 nTPM
  • white matter: 29 nTPM
  • thalamus: 28 nTPM
  • choroid plexus: 28 nTPM
  • pons: 27 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about MAPKAPK3.

Disease | AllUniProt

Conditions MAPKAPK3 is implicated in, by any mechanism.

Disease | GeneticClinVar

1 pathogenic / likely-pathogenic of 320 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.12
gnomAD pLI
0
gnomAD missense Z
1.44
DepMap mean gene effect
0.04
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of MAPKAPK3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads MAPKAPK3 as an antibody target. Whether an autoantibody or antibody against MAPKAPK3 could matter depends on whether native MAPKAPK3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

MAPKAPK3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label MAPKAPK3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/MAPKAPK3. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...